August 12, 2021
2 min watch
Save
VIDEO: Cyclosporine insert removes compliance issue from dry eye disease treatment
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Lee Shettle, DO, discusses results from a phase 1 trial investigating a novel hydrogel-based cyclosporine insert for the treatment of dry eye disease.